BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37794659)

  • 1. Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.
    Bauer RN; Xie Y; Beaudin S; Wiltshire L; Wattie J; Muñoz C; Alsaji N; Oliveria JP; Ju X; MacLean J; Sommer DD; Keith PK; Satia I; Cusack RP; O'Byrne PM; Sperinde G; Hokom M; Li O; Banerjee P; Chen C; Staton T; Sehmi R; Gauvreau GM
    Clin Exp Allergy; 2023 Nov; 53(11):1187-1197. PubMed ID: 37794659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma.
    Xie Y; Ju X; Beaudin S; Wiltshire L; Oliveria JP; MacLean J; Sommer DD; Cusack R; Li O; Banerjee P; Keith PK; O'Byrne PM; Bauer RN; Staton T; Gauvreau GM; Sehmi R
    Allergy; 2021 Sep; 76(9):2797-2808. PubMed ID: 33784411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies.
    Ellis AK; Soliman M; Steacy L; Boulay MÈ; Boulet LP; Keith PK; Vliagoftis H; Waserman S; Neighbour H
    Allergy Asthma Clin Immunol; 2015; 11(1):16. PubMed ID: 25945101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.
    Scadding GW; Calderon MA; Bellido V; Koed GK; Nielsen NC; Lund K; Togias A; Phippard D; Turka LA; Hansel TT; Durham SR; Wurtzen PA
    J Immunol Methods; 2012 Oct; 384(1-2):25-32. PubMed ID: 22759401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical symptoms and biomarkers of Bermuda grass-induced allergic rhinitis using the nasal allergen challenge model.
    Rawls M; Thiele J; Adams DE; Steacy LM; Ellis AK
    Ann Allergy Asthma Immunol; 2020 Jun; 124(6):608-615.e2. PubMed ID: 32173484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeatability of nasal allergen challenge results: Further validation of the allergic rhinitis clinical investigator collaborative protocols.
    Soliman M; Steacy LM; Thiele J; Adams DE; Neighbour HL; Ellis AK
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):607-613. PubMed ID: 29432965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.
    Scadding GW; Eifan AO; Lao-Araya M; Penagos M; Poon SY; Steveling E; Yan R; Switzer A; Phippard D; Togias A; Shamji MH; Durham SR
    Allergy; 2015 Jun; 70(6):689-96. PubMed ID: 25773990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Medical Therapy in Allergic Rhinitis: A Systematic Review and Meta-Analysis.
    Zhang K; Li AR; Miglani A; Nguyen SA; Schlosser RJ
    Am J Rhinol Allergy; 2022 Mar; 36(2):269-280. PubMed ID: 34546814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
    Lohia S; Schlosser RJ; Soler ZM
    Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo-controlled crossover trial.
    Mårtensson A; Nordström FU; Cervin-Hoberg C; Lindstedt M; Sakellariou C; Cervin A; Greiff L
    Clin Exp Allergy; 2022 Jun; 52(6):774-783. PubMed ID: 35075723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial.
    Ellis AK; Tsitoura DC; Quint D; Powley W; Lee LA
    Clin Exp Allergy; 2017 Sep; 47(9):1193-1203. PubMed ID: 28681506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy.
    Neighbour H; Soliman M; Steacy LM; Hickey P; Forbes B; Larché M; Ellis AK
    Clin Transl Allergy; 2018; 8():15. PubMed ID: 29682277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and reproducibility of nasal allergen challenge.
    Eguiluz-Gracia I; Testera-Montes A; González M; Pérez-Sánchez N; Ariza A; Salas M; Moreno-Aguilar C; Campo P; Torres MJ; Rondon C
    Allergy; 2019 Jun; 74(6):1125-1134. PubMed ID: 30667530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As-needed intranasal corticosteroid spray for allergic rhinitis: a systematic review and meta-analysis.
    Hoang MP; Chitsuthipakorn W; Seresirikachorn K; Snidvongs K
    Rhinology; 2022 Aug; 60(4):242-251. PubMed ID: 35379997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis.
    Greiff L; Persson CG; Svensson C; Enander I; Andersson M
    J Allergy Clin Immunol; 1995 Jul; 96(1):97-103. PubMed ID: 7542675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses.
    Erin EM; Leaker BR; Zacharasiewicz A; Higgins LA; Nicholson GC; Boyce MJ; de Boer P; Jones RC; Durham SR; Barnes PJ; Hansel TT
    Clin Exp Allergy; 2006 Apr; 36(4):458-64. PubMed ID: 16630150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
    Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability and reproducibility of biomarkers for the evaluation of anti-inflammatory therapy in allergic rhinitis.
    Boot JD; Chandoesing P; de Kam ML; Mascelli MA; Das AM; Gerth van Wijk R; de Groot H; Verhoosel R; Hiemstra PS; Diamant Z
    J Investig Allergol Clin Immunol; 2008; 18(6):433-42. PubMed ID: 19123434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.